tiprankstipranks
Achilles Therapeutics (ACHL)
NASDAQ:ACHL
Holding ACHL?
Track your performance easily

Achilles Therapeutics (ACHL) Income Statement

130 Followers

Achilles Therapeutics Income Statement

Last quarter (Q ), Achilles Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Achilles Therapeutics's net income was $―. See Achilles Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
----$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 36.58M$ 75.25M$ -78.38M$ -64.19M$ 33.73M$ 13.78M
Operating Income
$ -36.58M$ -75.25M$ -78.38M$ -64.19M$ -33.73M$ -13.78M
Net Non Operating Interest Income Expense
------
Other Income Expense
$ 6.87M$ -6.08M$ -7.32M$ -3.13M$ 531.00K$ -215.00K
Pretax Income
$ -29.71M$ -69.17M$ -71.06M$ -61.06M$ -33.20M$ -13.99M
Tax Provision
$ 55.00K$ 491.00K$ 111.00K$ 37.00K$ 3.00K$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -29.77M$ -69.67M$ -71.18M$ -61.10M$ -33.20M$ -13.99M
Basic EPS
$ -0.76$ -1.74$ -1.82$ -2.13$ -1.82$ -0.77
Diluted EPS
$ -0.76$ -1.74$ -1.82$ -2.13$ -1.82$ -0.77
Basic Average Shares
$ 78.42M$ 39.97M$ 39.14M$ 28.65M$ 18.20M$ 18.20M
Diluted Average Shares
$ 78.42M$ 39.97M$ 39.14M$ 28.65M$ 18.20M$ 18.20M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 36.58M$ 75.25M$ -78.38M$ -64.19M$ 33.73M$ 13.78M
Net Income From Continuing And Discontinued Operation
$ -29.77M$ -69.67M$ -71.18M$ -61.10M$ -33.20M$ -13.99M
Normalized Income
$ -29.77M---$ -33.20M$ -13.99M
Interest Expense
------
EBIT
$ -36.58M-$ -71.06M$ -61.06M$ -33.73M$ -13.78M
EBITDA
$ -35.66M-$ -67.38M$ -57.77M$ -32.95M$ -13.47M
Currency in USD

Achilles Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis